Skip Navigation

The Drug Industry Is Having Its Own DeepSeek Moment

www.wsj.com

wsj.com

5 comments
  • While that isn’t going away, chief executives of large pharmaceutical companies are broadening their horizons. Why spend $10 billion acquiring a U.S. biotech with a mid-stage drug when a similar molecule can be licensed from China for a fraction of the price?

    So these fuckers are going to run the research sector through the same outsourcing treatment they ran manufacturing won't they.

    I'm wondering what would happen if PRC doesn't profit maximize their product in the long run. As standard of living increases the cost of labor in China would get close to the cost of labor in the West. If the difference in cost of labor isn't a significant factor and Chinese product (manufacturing and IP like drugs) is sold close to the cost of labor and materials, wouldn't that force the Western firms to operate as non-profits? If they can't make significant profit on anything, won't that significantly disrupt the current capitalist model?